Researchers were assessing the safety of MTX102, which is being designed as a vaccine for type-1...
Featured articles
"We have improved the company's foundations to build the world's most customer-focused cannabis...
In an exclusive interview with Proactive, Namaste's interim CEO Meni Morim outlines his plans...
The company is partnering with Shanghai Fosun Long March Medical Science Co Ltd, a manufacturer...
Silence said the collaboration has the potential to bring in up to US$2bn in clinical,...
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours
Featured companies
Antibe Therapeutics is a publicly-traded biotechnology company pursuing a breakthrough advance...
Nemaura Medical Inc. is a medical technology company which has developed sugarBEAT® as a non-i...
We are a U.S.-based global company driving the acceleration of the discovery/development, manu...
A Transatlantic healthcare technology group
Through our US-UK network, we source, develop...
Summit Therapeutics is a leader in antibiotic innovation. Summit’s new mechanism antibiotics a...
Established in 1989 as a spin out from Queen Mary University, London, hVIVO is a trusted partn...
Global biotech Newswire
Researchers were assessing the safety of MTX102, which is being designed as a vaccine for type-1...
Two unnamed but ‘top-10 global’ cosmetics companies, have signed deals to use Integumen’s...
"We have improved the company's foundations to build the world's most customer-focused cannabis...
In an exclusive interview with Proactive, Namaste's interim CEO Meni Morim outlines his plans...
The company is partnering with Shanghai Fosun Long March Medical Science Co Ltd, a manufacturer...
Chris Avery has launched numerous glucose monitoring devices, stents and insulin pumps into the...
Reilly is being brought in to help Agile prepare for the potential commercialization of its lead...
Silence said the collaboration has the potential to bring in up to US$2bn in clinical,...
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours
Executive video interviews
Faron Pharmacuetical Oy’s (LON:FARN) clinical trial of anti-cancer drug Clevegen...
Lexagene Holding (CVE:LXG-OTCQB:LXXGF) Co-Founder and CEO Dr Jack Regan joined Steve...
Medexus Pharmaceuticals Inc (TSXV:MDP) (OTCQB:PDDPF) CEO Ken d’Entremont tells Proactive...
MMJ Group Holdings Ltd (ASX: MMJ) non-executive director Mike Curtis updates Proactive...
Supreme Heights is a recently launched platform, based in London, which CEO Patrick...
Zacks Small Cap Research Senior Biotechnology Analyst John Vandermosten talks to...
Team San Sanfilippo Foundation representatives told Proactive Investors the nonprofit...
Genedrive PLC (LON:GDR) CEO David Budd tells Proactive London's Andrew Scott he remains...
ReNeuron Group PLC's (LON:RENE) Michael Hunt caught up with Proactive London's Andrew...
Clive Richardson, chief executive of Akari Therapeutics PLC (NASDAQ:AKTX), introduces...
Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence talk Proactive...
Allergy Therapeutics PLC's (LON:AGY) CFO Nick Wykeman talks Proactive London's Andrew...
Big picture investment ideas in Biotech Capital
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours
Here we take a closer look at Genedrive PLC (LON:GDR)
Here we take a closer look at Clinigen, the specialty pharma group and AIM billionaire
Here we take a closer look at SkinBioTherapeutics, the life sciences group that is using...
Here we take a look at AIM-listed life sciences group, OptiBiotix Health
Here we take a closer look at Physiomics, the AIM company that owns a piece of software called...
The company’s high-pressure technologies can help drug makers produce protein-based...
Long-term fundamentals remain firmly in the seafood specialist's favour
Belgium-based company’s Nu.Q test screens for colorectal and prostate cancers, and may have the...
Capital Network Research
Shield Therapeutics PLC Heading for a US approval decision
May 09 2019
Shield Therapeutics (LON:STX) is making excellent progress having...
Avacta - interim results confirm progress
April 09 2019
Avacta Group PLC (LON:AVCT) reported interim results to...
Judges Scientific's focus is paying dividends
April 04 2019
Judges Scientific PLC (LON:JDG) posted strong 2018 full year...
Shield Therapeutics PLC - Feraccru: a potential game changer in the...
January 18 2019
Feraccru is a unique, non-salt, formulation oral iron: strong...
Avacta Group - Maximising Affimer's potential across therapeutics and...
October 03 2018
Over the last year or so, management has delivered significant progress in bringing their...
Judges Scientific PLC - 2018 Interim Results
September 21 2018
Judges Scientific reported results for the first half of 2018. The period included a...
Partners:
